New Zealand’s science-led response to the SARS-CoV-2 pandemic

New Zealand has avoided the major health impacts of the SARS-CoV-2 pandemic due to a strict country-wide lockdown, the end-goal of which was elimination rather than mitigation and suppression. The New Zealand government’s use of scientific expertise, spanning public health, infectious diseases, geno...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature immunology 2021-03, Vol.22 (3), p.262-263
Hauptverfasser:	Geoghegan, Jemma L., Moreland, Nicole J., Le Gros, Graham, Ussher, James E.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/255/2514 706/648 706/648/236 Advisory Committees Biomedical and Life Sciences Biomedicine Comment Communicable Disease Control Communicable Diseases, Imported Control COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 - transmission COVID-19 Vaccines - therapeutic use Disease Transmission, Infectious Emigration and Immigration Epidemics Evaluation Humans Immunology Infection control Infectious Diseases Mass Screening New Zealand New Zealand - epidemiology Pandemics Public Health Public health administration Public Policy SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	New Zealand has avoided the major health impacts of the SARS-CoV-2 pandemic due to a strict country-wide lockdown, the end-goal of which was elimination rather than mitigation and suppression. The New Zealand government’s use of scientific expertise, spanning public health, infectious diseases, genomics, modeling and immunology, has been one of the keys to the success of its SARS-CoV-2 elimination and control strategy.
ISSN:	1529-2908 1529-2916
DOI:	10.1038/s41590-021-00872-x